Evaluation of Tear Film Lipid Layer Thickness Change After Cataract Surgery
NCT ID: NCT02567565
Last Updated: 2015-10-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2015-05-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Meibomian Gland Dysfunction Before and After Cataract Surgery
NCT03276182
Strip Meniscometry in Dry Eye Evaluation
NCT06120894
SAS 1: Develop Ocular Disease (OSD) Diagnostic, Algorithms, and Management Protocols for Cataract Surgery
NCT07323264
Impact of Ophthalmic Surgeon Experience on Early Postoperative Central Corneal Thickness
NCT03685825
Prospective Health Assessment of Cataract Patients' Ocular Surface
NCT01016405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cataract patients
cataract patients undergoing phacoemulsification
LipiView
tear film lipid layer thickness measured by LipiView interferometer (TearScience Inc, Morrisville, NC)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LipiView
tear film lipid layer thickness measured by LipiView interferometer (TearScience Inc, Morrisville, NC)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
19 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tae-im Kim, MD, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Severance Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Yonsei University College of Medicine
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2015-0225
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.